Related Experiment Video

Updated: Mar 1, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K

An update on pediatric bronchiectasis

Danielle F Wurzel1,2, Anne B Chang3,4

  • 1a The Royal Children's Hospital , Parkville , Australia.

Expert Review of Respiratory Medicine
|May 26, 2017
PubMed

Insights

Pediatric bronchiectasis, a growing respiratory concern, lacks sufficient research and targeted treatments. Future strategies must focus on early life factors to improve long-term outcomes.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Research

Background:

  • Non-cystic fibrosis (CF) bronchiectasis is increasingly recognized globally, causing significant respiratory illness, mortality, and healthcare use.
  • Early origins of pediatric bronchiectasis are a critical research priority due to limited current treatments.
  • Existing pediatric treatments include antimicrobials, airway clearance, and vaccination, with new anti-inflammatory drugs in development.

Purpose of the Study:

  • To review current management strategies for pediatric bronchiectasis.
  • To discuss existing and emerging therapeutics, including non-pharmacological interventions.
  • To highlight the need for increased research into childhood bronchiectasis treatments.

Main Methods:

  • Review of current adult and pediatric data on bronchiectasis treatments.
  • Discussion of emerging therapeutic agents.
  • Analysis of preventative and surveillance strategies.

Main Results:

  • Current research on pediatric bronchiectasis treatments is notably scarce compared to cystic fibrosis.
  • Interventions for pediatric bronchiectasis are limited, underscoring a gap in evidence-based care.
  • Emerging therapeutics show promise but require further investigation.

Conclusions:

  • Tailored interventions are crucial for halting pediatric bronchiectasis at its onset.
  • Understanding early-life respiratory infections and immune interactions is key to developing preventative strategies.
  • Improved research and targeted therapies are imperative to enhance long-term outcomes for children with bronchiectasis.
Abstract

Keywords:
Bronchiectasischildrencoughtreatment

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.7K
P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.9K

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
960
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
590
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
903
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K